Vous êtes sur la page 1sur 1

PATENT RULING ASTRAZENECA BATTLES FDA

The UK drugs giant AstraZeneca has launched a legal attempt to overturn a ruling that would allow generic copies of its Seroquel antipsychotic drug to be sold in the US by the end of this month.

Seroquel by numbers

5th

biggest selling drug in the world

$4.1bn
worldwide sales in 2011

US sales in 2011

$5.8bn
AstraZeneca
SHARE PRICE, PENCE

1st

approved for schizophrenia in the US in 1997

3,400 3,200 3,000 2,800 2,600 2,400


2,885p

Seroquel accounts for

The Patent Cliff


Major patents expiring in 2012 Condition Company 2010 US sales

Plavix Seroquel

anti-platelet antipsychotic asthma Type 2 diabetics arthritis

Bristol-Myers Squibb/ Sanofi-Aventis AstraZeneca Merck Takeda Amgen

$6.15bn $3.75bn $3.22bn $3.35bn $3.30bn

17%
Q3 2010 Q4 Q1 2011 Q2 Q3 Q4 Q1 2012

Singulair Actos Enbrel

of AstraZeneca revenues in 2011

SOURCE: IBIS WORLD

Vous aimerez peut-être aussi